ACTIVE

S-Biomedic

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result259,6 k €+134,6 %over 1 year
Gross margin4,4 M €+48,7 %over 1 year
Equity1,9 M €+16,3 %over 1 year
Workforce12,2 ETP+6,1 %over 1 year

Identity

Source · BCE/KBO

S-Biomedic is a Public limited company incorporated in 2016. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 12,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0668.407.105
Incorporation
23/12/2016
Legal form
Public limited company
Registered office
Suzanne Tassierstraat 1
9052 Gent · FlandreSee on map
Contributed capital
2 266 238,00 €
Latest accounts
31/12/2025
Average workforce
12,2 ETP
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 10 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin4,4 M €3 M €3 M €-2,9 M €1,9 M €
EBITDA3,1 M €1,8 M €2 M €-4,3 M €926,7 k €
Operating result137 k €-930,8 k €-163 k €-6,1 M €-668,6 k €
Net result259,6 k €-750,9 k €78,8 k €-6,1 M €-633,4 k €
Balance sheet
Equity1,9 M €1,6 M €2,3 M €2,3 M €1,1 M €
Total assets5,9 M €7,9 M €8,4 M €6,9 M €3,1 M €
Cash2,8 M €3,9 M €4,8 M €5,3 M €2,4 M €
Debts615,9 k €2,7 M €2,2 M €4,6 M €2 M €
Other
Workforce12,2 ETP11,5 ETP11,4 ETP12,3 ETP10,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 19 ended

Active mandates

Christopher Sheldon

Director · since 16 décembre 2022 · until 25 avril 2028

Active
Dr. Gitta Neufang

Director · since 16 décembre 2022 · until 25 avril 2028

Active
Dr. Stefan Gallinat

Director · since 16 décembre 2022 · until 25 avril 2028

Active

Ended mandates

Oudova

Managing director · since 16 décembre 2022 · until 25 avril 2028 · 0786.916.953

Represented by Veronika Oudova

Ended
Christopher Sheldon

Director · since 15 décembre 2022 · until 25 avril 2028

Ended
Dr. Stefan Gallinat

Director · since 15 décembre 2022 · until 25 avril 2028

Ended
Kunal Ullhas Paymaster

Director · since 15 décembre 2021 · until 23 avril 2024

Ended

Other companies at this address

Suzanne Tassierstraat 1 9052 Gent
CompanyCBE no.
272BIO● Active
0762.638.249
AmphiStar● Active
0771.868.491
Biotope General Partner● Active
1023.886.864
Biotope Ventures● Active
0786.781.648
Biotope Ventures II● Active
1024.242.497
EU-LIFE● Active
1038.799.823
EU-SAGE● Active
0774.834.218
I-CHALLENGE● Active
1002.343.560
LO²CUS Gent● Active
0642.937.081
Obulytix● Active
0803.351.624
ORIONIS BIOSCIENCES● Active
0635.962.088
Rainbow Crops● Active
1022.560.538
Typcal Europe● Active
1028.922.352
VIB BIO-INCUBATOR● Active
0711.986.235
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY● Active
0456.343.923
Xpert Protein● Active
1014.642.467

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202616/05/202521/05/202407/06/202309/06/202217/05/2021
General meeting28/04/202622/04/202523/04/202425/04/202326/04/202227/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged modelCorrection31/12/202528/04/202614/07/2026DutchPDF
Abridged model31/12/202528/04/202605/05/2026DutchPDF
Abridged model31/12/202422/04/202516/05/2025DutchPDF
Abridged model31/12/202323/04/202421/05/2024DutchPDF
Abridged model31/12/202225/04/202307/06/2023DutchPDF
Abridged model31/12/202126/04/202209/06/2022DutchPDF
Abridged model31/12/202027/04/202117/05/2021DutchPDF
Abridged model31/12/201928/04/202008/06/2020DutchPDF
Micro model31/12/201823/04/201906/06/2019DutchPDF
Micro model31/12/201726/04/201825/06/2018DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 19 ended

Active mandates

Christopher Sheldon

Director · since 16 décembre 2022 · until 25 avril 2028

Active
Dr. Gitta Neufang

Director · since 16 décembre 2022 · until 25 avril 2028

Active
Dr. Stefan Gallinat

Director · since 16 décembre 2022 · until 25 avril 2028

Active

Ended mandates

Oudova

Managing director · since 16 décembre 2022 · until 25 avril 2028 · 0786.916.953

Represented by Veronika Oudova

Ended
Christopher Sheldon

Director · since 15 décembre 2022 · until 25 avril 2028

Ended
Dr. Stefan Gallinat

Director · since 15 décembre 2022 · until 25 avril 2028

Ended
Kunal Ullhas Paymaster

Director · since 15 décembre 2021 · until 23 avril 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates16/01/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other23/12/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates17/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/05/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares30/12/2024
    KAPITAAL - AANDELEN
    PDF
  • Mandates18/12/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office14/10/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates18/07/2024
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025259,6 k €↑
  2. 2024
    Annual accounts 2024-750,9 k €↓
  3. 2023
    Annual accounts 202378,8 k €↑
  4. 2022
    Annual accounts 2022-6,1 M €↓
  5. 2021
    Annual accounts 2021-633,4 k €↑
  6. 2020
    Annual accounts 2020-1,1 M €↑
  7. 2019
    Annual accounts 2019-1,1 M €↓
  8. 2017
    Annual accounts 2017-738,2 k €
  9. 23/12/2016
    IncorporationPublic limited company